Opposite effects of dibutyryl cyclic GMP and dibutyryl cyclic AMP on glucose 1,6-diphosphate levels and the activities of glucose 1,6-diphosphate phosphatase and phosphofructokinase in diaphragm muscle.
D000818:Animals; D003994:Bucladesine / Q000494:pharmacology*; D006152:Cyclic GMP / Q000031:analogs & derivatives*; D003964:Diaphragm / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism; D003995:Dibutyryl Cyclic GMP / Q000494:pharmacology*; D004789:Enzyme Activation; D019298:Glucose-6-Phosphate / Q000031:analogs & derivatives*; D005958:Glucosephosphates / Q000378:metabolism*; D008297:Male; D009130:Muscle, Smooth / Q000187:drug effects / Q000201:enzymology / Q000378:metabolism*; D010732:Phosphofructokinase-1 / Q000378:metabolism*; D010744:Phosphoric Monoester Hydrolases / Q000378:metabolism*; D051381:Rats
D005958:Glucosephosphates; D003995:Dibutyryl Cyclic GMP; D019298:Glucose-6-Phosphate; D003994:Bucladesine; C016473:glucose-1,6-bisphosphate; D010732:Phosphofructokinase-1; C014818:glucose 1,6-diphosphate phosphatase; D010744:Phosphoric Monoester Hydrolases; D006152:Cyclic GMP